{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:54:10Z","timestamp":1757616850353,"version":"3.44.0"},"reference-count":33,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2004,10,1]]},"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To summarise the epidemiological evidence on the relationship between second- (OC2) and thirdgeneration (OC3) oral contraceptives (OC) and the mortality associated with deep vein thrombosis (DVT) and myocardial infarction (MI), and to extrapolate and balance the evidence for these risks to the population of French OC users.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All studies published on the risk of MI during OC2 and OC3 use were analysed. For DVT the Committee for Proprietary Medicinal Products public assessment report published in 2001 and more recent studies published on this topic were used. The estimates of odds ratios (OR) for risk of death from DVT or MI were extracted from the published manuscripts. ORs were used to calculate the aetiological fraction of risk for death from DVT and MI in the population; the relative impact of OC3 compared to OC2 use was expressed as an excess risk of death overall and by age group for French women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with OC2, the use of OC3 would prevent a maximum of 24 deaths from MI per year and induce a maximum of 16 deaths. Conversely, OC3 would induce 282\u2013940 excess cases of DVT per year, resulting in 28\u201394 pulmonary embolisms and 3\u201319 deaths in the 4.7 million French OC users.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Balancing the evidence, it is difficult to conclude that the overall cardiovascular risk is significantly lower for either of the two OC schemes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1783\/0000000052972988","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T01:30:57Z","timestamp":1109986257000},"page":"37-39","source":"Crossref","is-referenced-by-count":4,"title":["Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis"],"prefix":"10.1136","volume":"31","author":[{"given":"Karin","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"B\u00e9gaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yola","family":"Moride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Metge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2005,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582\u20131588.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick, H.; Jick, S.S.; Gurewich, V.; Myers, M.W.; Vasilakis, C.","year":"1995","unstructured":"Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589\u20131593.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp, K.W.M.; Rosendaal, F.R.; Helmerhorst, F.M.; Buller, H.R.; Vandenbroucke, J.P.","year":"1995","unstructured":"Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593\u20131596.","journal-title":"Lancet"},{"key":"ref_4","first-page":"83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer, W.O.; Lewis, M.A.; Heinemann, L.A.; Thorogood, M.; MacRae, K.D.","year":"1996","unstructured":"Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 83\u201388.","journal-title":"Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ"},{"key":"ref_5","first-page":"88","article-title":"Third generation oral contraceptives and risk of myocardial infarction: an international case-control study","volume":"312","author":"Lewis, M.A.; Spitzer, W.O.; Heinemann, L.A.; MacRae, K.D.; Bruppacher, R.; Thorogood, M.","year":"1996","unstructured":"Lewis MA, Spitzer WO, Heinemann LA, MacRae KD, Bruppacher R, Thorogood M. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 88\u201390.","journal-title":"Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer, R.D.; Lawrenson, R.A.; Thompson, C.R.; Kennedy, J.G.; Hambleton, I.R.","year":"1997","unstructured":"Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83\u201388.","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer, R.D.; Todd, J.C.; Lewis, M.A.; MacRae, K.D.; Williams, T.J.","year":"1998","unstructured":"Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study. Contraception 1998; 57: 67\u201370.","journal-title":"Contraception"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptives and venous thromboembolism. A case-control study","volume":"57","author":"Lidegaard, O.; Edstrom, B.; Kreiner, S.","year":"1998","unstructured":"Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998; 57: 291\u2013301.","journal-title":"Contraception"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.159.1.65","article-title":"Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias","volume":"159","author":"Bloemenkamp, K.W.; Rosendaal, F.R.; Buller, H.R.; Helmerhorst, F.M.; Colly, L.P.; Vandenbroucke, J.P.","year":"1999","unstructured":"Bloemenkamp KW, Rosendaal FR, Buller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med 1999; 159: 65\u201370.","journal-title":"Arch Intern Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptives","volume":"354","author":"Herings, R.M.; Urquhart, J.; Leufkens, H.G.","year":"1999","unstructured":"Herings RM, Urquhart J, Leufkens HG. Venous thromboembolism among new users of different oral contraceptives. Lancet 1999; 354: 127\u2013128.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin, L.; Skegg, D.C.; Wilson, M.; Herbison, G.P.; Paul, C.","year":"2000","unstructured":"Parkin L, Skegg DC, Wilson M, Herbison GP, Paul C. Oral contraceptives and fatal pulmonary embolism. Lancet 2000; 355: 2133\u20132134.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.321.7270.1190","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis","volume":"321","author":"Jick, H.; Kaye, J.A.; Vasilakis-Scaramozza, C.; Jick, S.S.","year":"2000","unstructured":"Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 2000; 321: 1190\u20131195.","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa, S.; Blais, L.; Spitzer, W.O.; Cusson, J.; Lewis, M.; Heinemann, L.","year":"1997","unstructured":"Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception 1997; 56: 141\u2013146.","journal-title":"Contraception"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa, S.; Spitzer, W.O.; Rainville, B.; Cusson, J.; Lewis, M.; Heinemann, L.","year":"2000","unstructured":"Suissa S, Spitzer WO, Rainville B, Cusson J, Lewis M, Heinemann L. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod 2000; 15: 817\u2013821.","journal-title":"Hum Reprod"},{"key":"ref_15","first-page":"61","article-title":"Oral contraceptives and risk of venous thromboembolism: impact of duration of use","volume":"57","author":"Farley, T.M.; Meirik, O.; Marmot, M.G.; Chang, C.L.; Poulter, N.R.","year":"1998","unstructured":"Farley TM, Meirik O, Marmot MG, Chang CL, Poulter NR. Oral contraceptives and risk of venous thromboembolism: impact of duration of use. Contraception 1998; 57: 61\u201365.","journal-title":"Contraception"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","article-title":"The differential risk of oral contraceptives: the impact of full exposure history","volume":"14","author":"Lewis, M.A.; MacRae, K.D.; Kuhl-Habichl, D.; Bruppacher, R.; Heinemann, L.A.; Spitzer, W.O.","year":"1999","unstructured":"Lewis MA, MacRae KD, Kuhl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO. The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod 1999; 14: 1493\u20131499.","journal-title":"Hum Reprod"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/14.6.1500","article-title":"Venous thromboembolic disease and combined oral contraceptives: a reanalysis of the MediPlus database","volume":"14","author":"Todd, J.; Lawrenson, R.; Farmer, R.D.; Williams, T.J.; Leydon, G.M.","year":"1999","unstructured":"Todd J, Lawrenson R, Farmer RD, Williams TJ, Leydon GM. Venous thromboembolic disease and combined oral contraceptives: a reanalysis of the MediPlus database. Hum Reprod 1999; 14: 1500\u20131505.","journal-title":"Hum Reprod"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer, R.D.; Lawrenson, R.A.; Todd, J.C.; Williams, T.J.; MacRae, K.D.; Tyrer, F.","year":"2000","unstructured":"Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae KD, Tyrer F, et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol 2000; 49: 580\u2013590.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren, J.M.; Algra, A.; Grobbee, D.E.","year":"2001","unstructured":"Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 2001; 323: 131\u2013134.","journal-title":"BMJ"},{"year":"2001","unstructured":"European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products, Public Assessment Report (EMEA\/CPMP\/2201\/01\/en\/Final). Combined oral contraceptives and venous thromboembolism. 2001. http:\/\/www.emea.eu.int\/pdfs\/human\/regaffairs\/0220101en.pdf)[Accessed 3 February 2004].","article-title":"European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products, Public Assessment Report (EMEA\/CPMP\/2201\/01\/en\/Final). Combined oral contraceptives and venous thromboembolism","key":"ref_20"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(01)00234-7","article-title":"Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a metaanalysis and formal sensitivity analysis","volume":"64","author":"Hennessy, S.; Berlin, J.A.; Kinman, J.L.; Margolis, D.J.; Marcus, S.M.; Strom, B.L.","year":"2001","unstructured":"Hennessy S, Berlin JA, Kinman JL, Margolis DJ, Marcus SM, Strom BL. Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a metaanalysis and formal sensitivity analysis. Contraception 2001; 64: 125\u2013133.","journal-title":"Contraception"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard, O.; Edst\u00f6m, B.; Kreiner, S.","year":"2002","unstructured":"Lidegaard O, Edst\u00f6m B, Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception 2002; 65: 187\u2013196.","journal-title":"Contraception"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case-control study","volume":"318","author":"Dunn, N.; Thorogood, M.; Faragher, B.; de Caestecker, L.; MacDonald, T.M.; McCollum, C.","year":"1999","unstructured":"Dunn N, Thorogood M, Faragher B, de Caestecker L, MacDonald TM, McCollum C, et al. Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ 1999; 318: 1579\u20131583.","journal-title":"BMJ"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction combined oral contraceptives: results of an international multicentre casecontrol study","volume":"349","author":"Organization, World Health","year":"1997","unstructured":"World Health Organization. Acute myocardial infarction combined oral contraceptives: results of an international multicentre casecontrol study. Lancet 1997; 349: 1202\u20131209.","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","article-title":"The use of oral contraceptives and occurrence of acute myocardial infarction in young women: results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"56","author":"Lewis, M.A.; Heinemann, L.A.; Spitzer, W.O.; MacRae, K.D.; Bruppacher, R.","year":"1997","unstructured":"Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R. The use of oral contraceptives and occurrence of acute myocardial infarction in young women: results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception 1997; 56: 129\u2013140.","journal-title":"Contraception"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis, B.C.; van den Bosch, M.A.; Kemmeren, J.M.; Cats, V.M.; Helmerhorst, F.M.; Algra, A.","year":"2001","unstructured":"Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001; 345: 1787\u20131793.","journal-title":"N Engl J Med"},{"key":"ref_27","first-page":"74","article-title":"Oral contraceptives and acute myocardial infarction: a case-control study (Abstract)","volume":"1","author":"Lidegaard, O.; Estr\u00f6m, B.","year":"1996","unstructured":"Lidegaard O, Estr\u00f6m B. Oral contraceptives and acute myocardial infarction: a case-control study (Abstract). Eur J Contracept Reprod Health Care 1996; 1: 74.","journal-title":"Eur J Contracept Reprod Health Care"},{"author":"PubMed","unstructured":"PubMed. National Library of Medicine. NCBI Databases. http:\/\/www.ncbi.nlm.nih.gov\/pubmed [Accessed 23 August 2004].","article-title":"National Library of Medicine. NCBI Databases","key":"ref_28"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal, FR","year":"1999","unstructured":"Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167\u20131173.","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/humrep\/deg215","article-title":"Contraception: from accessibility to efficiency","volume":"18","author":"Bajos, N.; Leridon, H.; Goulard, H.; Oustry, P.; N, Job-Spira; the COCON Group","year":"2003","unstructured":"Bajos N, Leridon H, Goulard H, Oustry P, Job-Spira N and the COCON Group. Contraception: from accessibility to efficiency. Hum Reprod 2003; 18: 994\u2013999.","journal-title":"Hum Reprod"},{"author":"1080 [23 August 2004].","unstructured":"Genderand age-specific mortality rates for the French general population published yearly by the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM). http:\/\/sc8.vesinet.inserm.fr:1080 [Accessed 23 August 2004].","article-title":"Genderand age-specific mortality rates for the French general population published yearly by the","key":"ref_31"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/humupd\/5.6.627","article-title":"The \u2018pill scare\u2019: the responses of authorities, doctors and patients using oral contraceptives","volume":"5","author":"Szarewski, A.; Mansour, D.","year":"1999","unstructured":"Szarewski A, Mansour D. The \u2018pill scare\u2019: the responses of authorities, doctors and patients using oral contraceptives. Hum Reprod Update 1999; 5: 627\u2013632.","journal-title":"Hum Reprod Update"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/humrep\/17.9.2307","article-title":"Myocardial infarction and third generation oral contraceptives: aggregation of recent studies","volume":"17","author":"Spitzer, W.O.; Faith, J.M.; MacRae, K.D.","year":"2002","unstructured":"Spitzer WO, Faith JM, MacRae KD. Myocardial infarction and third generation oral contraceptives: aggregation of recent studies. Hum Reprod 2002; 17: 2307\u20132314.x","journal-title":"Hum Reprod"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/0000000052972988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T20:23:06Z","timestamp":1757103786000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/0000000052972988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1,1]]},"published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1783\/0000000052972988"],"URL":"https:\/\/doi.org\/10.1783\/0000000052972988","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}